Search Results - "Oster, W"

Estimating Mineral Requirements of Wild Herbivores: Modelling Arctic Caribou ( Rangifer tarandus granti ) in Summer by Oster, Keith W, Gustine, David D, Smeins, Fred E, Barboza, Perry S

“…Mineral requirements are poorly described for most wildlife. Consequently, the role of forage minerals in movement and productivity are poorly understood for…”
Get full text

Mineral constraints on arctic caribou (Rangifer tarandus): a spatial and phenological perspective by Oster, K. W., Barboza, P. S., Gustine, D. D., Joly, K., Shively, R. D.

“…Arctic caribou (Rangifer tarandus) have the longest terrestrial migration of any ungulate but little is known about the spatial and seasonal variation of…”
Get full text

Selective antagonism of the G protein-coupled receptor DRD2 contributes to the antitumor efficacy of small molecule ONC201 by Madhukar, N.S, Kline, C.L.B, Prabhu, V.V, Elemento, O, Rucker, J.B, Doranz, B.J, Oster, W, El-Deiry, W.S, Allen, J.E

“…Background: GPCRs control signaling pathways that are important for tumor growth and metastasis, such as ERK and Akt. While GPCRs are targeted by a number of…”
Get full text

Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer by Planting, A. S. T., Catimel, G., de Mulder, P. H. M., de Graeff, A., Höppener, F., Verweij, I., Oster, W., Vermorken, J. B.

“…Background: Cisplatin is one of the most active cytotoxic agents available for the treatment of patients with head and neck cancer. In a previous phase II…”
Get full text

Gemcitabine for relapsed or resistant lymphoma by Savage, D. G., I Rule, S. A., Tighe, M., Garrett, T. J., Oster, W. M., Lee, R. T., Ruiz, J., Heitjan, D., Keohan, M. L., Flamm, M., Johnson, S. A.

“…Background: Gemcitabine therapy has not been widely assessed in the treatment of hematological malignancies. We have examined the efficacy and safety of…”
Get full text

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: Modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor by HADDAD, Robert I, WEINSTEIN, Lisa J, DEROSA, Carolyn, YULE, Murray, MILLER, Linda P, LODA, Massimo, POSNER, Marshall R, SHAPIRO, Geoffrey I, WIECZOREK, Tad J, BHATTACHARYA, Nandita, RAFTOPOULOS, Harry, OSTER, Martin W, XINXIN ZHANG, LATHAM, Vaughan M, COSTELLO, Rosemary, FAUCHER, Jarrod

“…E7070 is a synthetic sulfonamide cell cycle inhibitor that induces hypophosphorylation of the retinoblastoma (Rb) protein and G(1) arrest in vitro. This Phase…”
Get full text

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences by Capizzi, R.L., Oster, W.

“…The clinical trials described in this review indicate that amifostine protects normal tissues from the toxicities of various antitumour regimens. In a…”
Get full text

Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 by Rustin, G J, Nelstrop, A E, Crawford, M, Ledermann, J, Lambert, H E, Coleman, R, Johnson, J, Evans, H, Brown, S, Oster, W

“…A phase II study was performed of oral altretamine in 71 patients with ovarian carcinoma who entered clinical complete remission with CA125 levels less than 35…”
Get more information

Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control by OSTER, W, CICCO, N. A, KLEIN, H, HIRANO, T, KISHIMOTO, T, LINDEMANN, A, MERTELSMANN, R. H, HERRMANN, F

“…Autonomous in vitro growth of myeloid leukemic colony-forming cells may in part result from autocrine production of colony-stimulating factors (CSF). Some…”
Get full text

Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma by Yoon, Angela J, Wang, Shuang, Shen, Jing, Robine, Nicolas, Philipone, Elizabeth, Oster, Martin W, Nam, Albert, Santella, Regina M

“…MicroRNAs (miRs) control cell growth, apoptosis and differentiation, and thus play a key role in carcinogenesis. Identification of a set of miRs that…”
Get full text

Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia by Savage, David G., Cohen, Neil S., Hesdorffer, Charles S., Heitjan, Daniel, Oster, Martin W., Garrett, Thomas J., Bar, Michael, del Prete, Salvatore, March, Robert, Lonberg, Mathew, Talbot, Susan, Mears, J. Gregory, Flamm, Michael, Taub, Robert N., Nichols, Gwen

“…As both fludarabine and rituximab are active against indolent lymphoproliferative disorders, we have studied the combination of fludarabine and rituximab in…”
Get full text

Tumor Necrosis Factor (TNF)-alpha but not TNF-beta Induces Secretion of Colony Stimulating Factor for Macrophages (CSF-1) by Human Monocytes by Oster, W., Lindemann, A., Horn, S., Mertelsmann, R., Herrmann, F.

“…Tumor necrosis factor (TNF)-alpha has been identified as a major inducer of colony stimulating factor (CSF)-secretion by human vascular endothelial cells and…”
Get full text

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study by BETTICHER, D. C, ANDERSON, H, RANSON, M, MEELY, K, OSTER, W, THATCHER, N

“…Amifostine (WR-2721), a thiol compound, has been shown to protect normal tissue from alkylating agents and cisplatin-induced toxicity without loss of…”
Get full text

Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor by Herrmann, F, Schulz, G, Lindemann, A, Meyenburg, W, Oster, W, Krumwieh, D, Mertelsmann, R

“…The in vivo effect of yeast-derived recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) was investigated in 30 patients with…”
Get more information

White coat pockets by Oster, M W

Get full text

Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes by Lindemann, A, Riedel, D, Oster, W, Ziegler-Heitbrock, H W, Mertelsmann, R, Herrmann, F

“…Granulocyte-macrophage colony-stimulating factor (GM-CSF) is known as an inducer of proliferation and functional activation of myeloid cells. This study was…”
Get full text

Hematologic Effects of Recombinant Human Granulocyte Colony-Stimulating Factor in Patients With Malignancy by Lindemann, Albrecht, Herrmann, Friedhelm, Oster, Wolfgang, Haffner, Gerd, Meyenburg, Walter, Souza, Larry M., Mertelsmann, Roland

“…The effect of recombinant human granulocyte colony-stimulating factor (G-CSF) on hematologic parameters was evaluated in a phase I clinical study in 18…”
Get full text

More on reports of esophageal cancer with oral bisphosphonate use by Siris, Ethel S, Oster, Martin W, Bilezikian, John P

Get full text

Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils by Lindemann, A, Riedel, D, Oster, W, Meuer, SC, Blohm, D, Mertelsmann, RH, Herrmann, F

“…The purpose of this study was to determine whether human polymorphonuclear neutrophils (PMN), which share a common cell lineage with macrophages, could produce…”
Get full text

Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration by Oster, W, Herrmann, F, Gamm, H, Zeile, G, Lindemann, A, Müller, G, Brune, T, Kraemer, H P, Mertelsmann, R

“…This clinical trial was performed to study the effects of intravenously (IV) administered recombinant human (rh) erythropoietin (EPO) at escalating doses (150,…”
Get more information